Yin Wen-Yao, Wei Chang-Kuo, Tseng Kuo-Chih, Lin Shih-Pin, Lin Chun-Hung, Chang Chun-Ming, Hsu Ta-Wen
Department of Surgery, Buddhist Dalin Tzu Chi General Hospital, Chia-Yi, Taiwan.
Hepatogastroenterology. 2009 Jul-Aug;56(93):998-1006.
BACKGROUND/AIMS: Although laparoscopic colorectal cancer surgery is not widely used for several reasons especially for concerning inadequate resection, recent data showed equivalent oncologic outcomes between open colectomy (OC) and laparoscopic-assisted colectomy (LAC). However, there is no clinical trial for the LAC supported by hand-assisted laparoscopic colectomy (HALC), named as LAC/HALC.
Patients were assigned to either OC or LAC/HALC group. Clinical data, operation times, conversion rates from LAC to HALC, complications, early results, and long-term results were analyzed retrospectively.
The short-term outcomes including pain, ambulation, oral resumption, wound infections, and hospital stays were favorable for LAC/HALC group. HALC was subsequently required in seven LAC cases but none of them required open colectomies. Functional recovery was the benchmark for early discharge for LAC/HALC group. Specimen size and number of lymph nodes harvested were similar. Local recurrence, disease-free and overall survival rates were comparable.
The current study demonstrated that LAC/HALC was associated with favorable recoveries even in oncologic clearance in the long-term follow-up. HALC reduces the conversion rate from LAC to OC and maintains the benefits of minimal invasive surgery. Therefore, we suggest LAC/HALC is a suitable surgical hybrid for the treatment of resectable colorectal cancers.
背景/目的:尽管由于多种原因,尤其是担心切除不充分,腹腔镜结直肠癌手术尚未广泛应用,但最近的数据显示,开放结肠切除术(OC)和腹腔镜辅助结肠切除术(LAC)的肿瘤学结局相当。然而,目前尚无关于手辅助腹腔镜结肠切除术(HALC)辅助的LAC(称为LAC/HALC)的临床试验。
将患者分为OC组或LAC/HALC组。对临床数据、手术时间、LAC转为HALC的转化率、并发症、早期结果和长期结果进行回顾性分析。
LAC/HALC组的短期结局,包括疼痛、活动能力、经口进食恢复情况、伤口感染和住院时间等均较好。7例LAC病例随后需要行HALC,但均无需行开放结肠切除术。功能恢复是LAC/HALC组早期出院的基准。标本大小和采集的淋巴结数量相似。局部复发、无病生存率和总生存率相当。
当前研究表明,即使在长期随访的肿瘤清除方面,LAC/HALC也具有良好的恢复效果。HALC降低了LAC转为OC的转化率,并保持了微创手术的益处。因此,我们认为LAC/HALC是治疗可切除结直肠癌的一种合适的手术方式。